Background: Low folate concentrations are inversely associated with birth defects, including neural tube defects, congenital heart disease and oral clefts. Conversely, high folate concentrations may be associated with adverse outcomes, including increased risk of colorectal cancer among those with pre-existing neoplasms. The purpose of our study was to investigate the folate status of a nationally representative sample of Canadians, including a subset of women of childbearing age.
Methods:
We examined red blood cell folate concentrations among members of the general population aged 6-79 years (n = 5248) and separately among women of childbearing age (15-45 yr, n = 1162), as recorded by the Canadian Health Measures Survey and measured by immunologic assay. We assessed the data for significant differences by age, sex and socioeconomic status.
Results: Less than 1% of Canadians showed folate deficiency (red blood cell folate < 305 nmol/L) and 40% showed high folate concentrations (> 1360 nmol/L). Among women of childbearing age, 22% showed concentrations below those considered optimal for maximal neural tube defect-risk reduction (< 906 nmol/L). Significant differences by age and socio-economic status, but not sex, were evident in median red blood cell folate concentrations, although concentrations in all groups exceeded recommended levels. No differences by age or income were found among women of childbearing age.
Interpretation: Folate deficiency is virtually nonexistent in the Canadian population, although high folate concentrations are evident. Additional research is needed to better understand the determinants of red blood cell folate among women of childbearing age who have concentrations below levels that are maximally protective against neural tube defects. Ongoing monitoring of the folate status of Canadians and the relationship between red blood cell folate and health outcomes is warranted. to achieve a nationally representative crosssectional sample. The final sample is representative of approximately 96.3% of the Canadian population, and included 5604 Canadians aged 6 to 79 years balanced by sex in each of the following age groups: 6-11, 12-19, 20-39, 40-59 and 60-79 years.
Survey methods
Data were collected between March 2007 and February 2009. A Statistics Canada interviewer administered a detailed in-home health questionnaire, which included items about sociodemographic characteristics. One day to six weeks later, blood samples were taken by a certified phlebotomist in a mobile examination centre to measure a variety of analytes, including red blood cell folate. 10 Of the 8772 dwellings selected, 69.6% agreed to participate; 88.3% participated in the household survey and, of those, 84.9% attended the mobile clinic. The overall response rate was 51.7%. Implied consent was obtained by household and a comprehensive consent process was employed in the clinic.
Ethics approval for the Canadian Health Measures Survey was obtained from the Health Canada Research Ethics Board and for this secondary data analysis from the Children's Hospital of Eastern Ontario and University of Ottawa Research Ethics Boards.
Blood sampling
Blood was taken from 5373 participants in the Canadian Health Measures Survey, with 5248 providing a usable sample for red blood cell folate measurement. Participants who refused to participate in the blood draw or did not have a usable sample were excluded (n = 356).
Red blood cell folate concentration
Red blood cell folate allows for an estimate of tissue folate stores. Venipuncture samples were collected in EDTA-treated vacutainers, then immediately processed on-site. After hema tocrit measurement, aliquots of whole blood were frozen, stored at -20°C and shipped on dry ice weekly to the Health Canada Nutrition Laboratory. 10 Samples were thawed, diluted (1-in-26) with 0.5% ascorbic acid solution, allowed to incubate (180°C) at room temperature and then analyzed for folate using the Immulite 2000 immunoassay (Siemens Canada Ltd.). 11 Red blood cell folate concentration was calculated from the measured whole-blood folate concentration adjusting for red blood cell volume, without correction for plasma folate concentration. Accuracy and reproducibility of these procedures were assessed using the manufacturers' serum controls (Con6: Trilevel multiconstituent control) and whole blood controls (BioRad Lyphochek Trilevel, Biorad Laboratories). Serum controls had an interassay coefficient of variation of less than 5%, and all analyzed controls (serum, whole blood) were within 10% of target values.
Deficient folate status was defined as a red blood cell folate concentration of less than 305 nmol/L (< 135 ng/mL), a cut-off defined by the Institute of Medicine based on several studies reporting the appearance of hypersegmented neutrophils, a characteristic of megaloblastic anemia, at red blood cell folate concentrations below this level. 12 The cut-off for folate status considered optimal for minimizing the risk of neural tube defects among women of childbearing age was set at 906 nmol/L or greater (≥ 400 ng/mL) and has been adopted by experts in the field.
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The concentration of red blood cell folate at which adverse effects occur in association with high intakes of folic acid is unknown, and no universally accepted cut-off is available. Leading researchers in the area have used distribution cut-offs from the National Health and Nutrition Examination Survey data in the United States to establish a high serum folate cut-off, but this has not been done for red blood cell folate. [15] [16] [17] Given that recent national Canadian data are unavailable, a similar but more conservative approach was taken to establish a cut-off for high red blood cell folate concentration from the most recent postfortification national American data. Therefore, a red blood cell folate concentration of greater than 1360 nmol/L (> 600 ng/mL), which reflects the 97th percentile from the National Health and Nutrition Examination Survey (1999) (2000) (2001) (2002) (2003) (2004) , was chosen as a cut-off for high red blood cell folate.
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Selected socio-demographic factors
The age groups of the Canadian Health Measures Survey sample were used for analyses, and a variable for women of childbearing age (15-45 years) was created. Socio-economic status was examined by per-person household income equivalents (which grouped respondents into quartiles after adjusting for family size and composition) and by highest level of household education (less than secondary, secondary graduation, some postsecondary, postsecondary graduation).
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Statistical analysis
Descriptive statistics (frequencies, medians, percentiles) were used to describe the population and estimate red blood cell folate concentrations by age, sex and socio-economic status. Red blood cell folate in the general population was assessed for deficiency and high concentrations, whereas women of childbearing age were examined for concentrations below those considered optimal for minimizing the risk of neural tube defects. 12, 13 Differences between sex and age groups by education level and income quartile were examined using t tests. All estimates were based on weighted data to represent the Canadian population. Variance estimation (95% confidence intervals) and significance testing (t test) were based on the bootstrap technique to account for the complex sampling design. 19 Significance was defined as a p value of < 0.05 and a Bonferroni adjustment was applied in cases of multiple comparisons.
Results
A demographic description of the population by age, sex, income and education can be found in Table 1 . Overall, almost 100% of Canadians met or exceeded the cut-off level in the general population for deficiency of red blood cell folate concentration (< 305 nmol/L). High red blood cell folate concentrations were found in 40% (> 1360 nmol/L) of the general population. Among women of childbearing age, 22% were below the cut-off level for concentration of red blood cell folate considered optimal for minimizing the risk of neural tube defects (< 906 nmol/L).
Median red blood cell folate concentrations were highest among participants aged 60 to 79 years (1409 nmol/L) and lowest among participants aged 12 to 19 years (1120 nmol/L) ( Table  2 ). No significant difference in median red blood cell folate concentration between sexes was found. Elevated red blood cell folate concentrations across each percentile were evident, with the 5th percentile consistently above the cut-off level for fo- Note: CI = confidence interval. *Comprises participants with a measured value of red blood cell folate concentration (n = 5248, data unavailable n = 356). †Estimate was not provided because of extreme sampling variability or small sample size. If the coefficient of variation of the estimate was greater than 33%, the estimate is indicated as being less than the upper limit of 95% CI. ‡Data should be interpreted with caution because of high sampling variability (coefficient of variation ≥ 16.6 and < 33.3).
late deficiency. Cumulative percent distributions for females and males by age are shown separately in Figure 1 . Significant differences in median red blood cell folate concentrations by income and education were few and inconsistent across age and sex groups (Appendix 1, available at www .cmaj .ca /cgi /content /full /cmaj .100568 /DC1). No consistent differences in median red blood cell folate values by age and socio-economic status were evident among women of childbearing age.
Interpretation
Our study used the recently released Canadian Health Measures Survey data set to examine the folate status of the Canadian population. Folate deficiency was extremely low in the general population, though high concentrations of red blood cell folate were common. More than 20% of Canadian women of childbearing age had a red blood cell folate concentration below that considered optimal for maximal reduction of risk of neural tube defects. 13 Differences by age and socio-economic status were seen in the general population but not among women of childbearing age.
Given that comparable national-level Canadian data are unavailable, the Canadian Health Measures Survey was modelled after the National Health and Nutrition Examination Survey. The United States also fortifies grain products with folic acid, making the American survey an appropriate comparator. 2 0 In the period of 2005 to 2006 (postfortification), the prevalence of folate deficiency in the American population was similar to that reported herein. Findings from postfortification studies of subgroups of Canadians show comparable results related to deficiency, and increases in circulating folate concentrations. For example, low rates of postfortification deficiency (< 1%) were found in a retrospective, population-based study involving Ontarian women of childbearing age, with the prefortification geometric mean for red blood cell folate increasing postfortification (527 to 741 nmol/L). 8 In a sample of Newfoundlanders aged 65 years or older, deficiency was less than 1.6% with a pre-to postfortification increase in red blood cells of 625 to 818 nmol/L. 9 In a 2008 Ontario review of laboratory databases, 40% of women of childbearing age were not achieving a red blood cell folate concentration of 906 nmol/L or greater. 21 Further, a recent randomized controlled trial in Toronto involving pregnant women, most of whom were consuming prenatal supplements containing folic acid (1 mg/d), showed a baseline geometric mean red blood cell folate in three groups that ranged from 2453 to 3635 nmol/L. 22 Some medical practitioners argue that many women of childbearing age need high-dose folic acid supplements and that doubling the level of folic acid fortification in the food supply should be considered. 23, 24 This argument has sparked considerable debate because folic acid fortification targets women of childbearing age by exposing the entire population to higher levels of folic acid. Given the absence of folate defi- adverse effects associated with high levels of folic acid, including increased risk of certain cancers among those with pre-existing neoplasms, further attempts to improve the folate status of Canadian women of childbearing age by increasing fortification levels should be approached cautiously.
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Strengths and limitations
The main strengths of our study include a large, nationally representative sample and directly measured biomarkers. This research is limited by its inability to establish causation because of the cross-sectional nature of the Canadian Health Measures Survey. Further, although red blood cell folate is defined by the Institute of Medicine as the primary biochemical index to establish dietary reference intakes, there are significant interlaboratory differences in values obtained for red blood cell folate. 12, 29 As such, study-to-study comparisons need to be performed with caution. Although the cut-offs used in our study are undoubtedly assay-dependent, it is standard practice to use the same cut-off values regardless of the method used to measure of red blood cell folate concentration. For example, the US Centres for Disease Control and Prevention reported that at least one competitive binding assay resulted in red blood cell folate concentrations that were about 30% lower than either microbiological or liquid chromatography-tandem mass spectrometry. 30 Interestingly, it was with the microbiological assay that the cut-off considered optimal for maximal reduction of risk of neural tube defects was established. To minimize the aforementioned limitation, strict quality control procedures were employed in our investigation to ensure both accuracy and precision of the red blood cell folate measurements.
Conclusion
Folate deficiency is virtually nonexistent in the Canadian population, regardless of income or education, and high folate concentrations are evident. Many women of childbearing age are still not achieving the concentrations considered optimal for maximal reduction of risk of neural tube defects. Although food insecurity has been identified previously as a risk factor for low folate intake, 31 the median red blood cell folate concentration among women of childbearing age did not differ by income or education in our study.
Investigations into the determinants of suboptimal folate status are needed to develop intervention strategies to further mitigate neural tube defects. Given the high red blood cell folate concentrations reported herein and speculation that exposure to high concentrations may have undesirable consequences for some, ongoing monitoring of the folate status of Canadians and study of the relation between red blood cell folate and health outcomes is warranted.
